These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16649336)

  • 21. Understanding therapeutic drug monitoring.
    Shirrell D; Gibbar-Clements T; Dooley R; Free C
    Am J Nurs; 1999 Jan; 99(1 Pt 1):42-4. PubMed ID: 9932054
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug dosing in the elderly patients with chronic kidney disease.
    Olyaei AJ; Bennett WM
    Clin Geriatr Med; 2009 Aug; 25(3):459-527. PubMed ID: 19765493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis-associated increase in the saliva level of paroxetine.
    Tsuruta T; Tanaka K; Ishikawa K; Yang C; Ueki H; Matsunaga M; Tatebayashi H; Yamada S
    J Clin Psychopharmacol; 2009 Dec; 29(6):619-20. PubMed ID: 19910739
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interactions with peroral anticoagulants (AC)].
    Christensen HR
    Ugeskr Laeger; 2000 Feb; 162(9):1253. PubMed ID: 10741239
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine early therapeutic drug monitoring is necessary during the first week of life.
    Stolk LM; Guillaume C
    Clin Pharmacol Ther; 2003 Jan; 73(1):131; author reply 131-2. PubMed ID: 12545151
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.
    Yang Z; Wang S
    J Immunol Methods; 2008 Jul; 336(2):98-103. PubMed ID: 18547583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of immunosuppressive drug monitoring in children.
    Filler G
    Transplant Proc; 2007 May; 39(4):1241-3. PubMed ID: 17524944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of factors influencing tacrolimus levels and immunoassay bias in renal transplantation.
    Borrows R; Chusney G; Loucaidou M; James A; Goel S; Borrows S; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    J Clin Pharmacol; 2007 Aug; 47(8):1035-42. PubMed ID: 17660485
    [No Abstract]   [Full Text] [Related]  

  • 30. [Special therapy in chronic renal disease (author's transl)].
    Zazgornik J
    Acta Med Austriaca; 1980; 7(4-5):138-9. PubMed ID: 7246017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A. Classification of antibiotics. 5/12 The aminosides].
    Hintzy E; Mandy B; Woronoff-Lemsi MC
    Soins; 2002 Nov; (670):51-2. PubMed ID: 12465381
    [No Abstract]   [Full Text] [Related]  

  • 34. [Volatile Anaesthetics are Outdated--Contra].
    Hobbhahn J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Apr; 39(4):223-8. PubMed ID: 15098171
    [No Abstract]   [Full Text] [Related]  

  • 35. Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid.
    van Hest RM
    J Postgrad Med; 2006; 52(4):244. PubMed ID: 17191354
    [No Abstract]   [Full Text] [Related]  

  • 36. ESA payment changes: chasing a moving target.
    Sargent JA
    Nephrol News Issues; 2008 Jan; 22(1):36-7. PubMed ID: 18271437
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral anticoagulation monitoring.
    Macaulay D
    Br J Gen Pract; 1997 Nov; 47(424):747-8. PubMed ID: 9519527
    [No Abstract]   [Full Text] [Related]  

  • 38. A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients.
    Perry SL; O'Shea SI; Byrne S; Szczech LA; Ortel TL
    Thromb Haemost; 2006 Dec; 96(6):750-5. PubMed ID: 17139369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?
    El-Agroudy AE; Ismail AM; Nassar M; Ghoneim MA
    Exp Clin Transplant; 2008 Dec; 6(4):282-6. PubMed ID: 19338490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simpler approaches to aminoglycoside monitoring.
    Matthews SJ; Chow MS
    Am J Hosp Pharm; 1994 Nov; 51(22):2847-8. PubMed ID: 7856616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.